Novel strategies for immuno-oncology breakthroughs with cell therapy

Novel strategies for immuno-oncology breakthroughs with cell therapy

Abstract Cell therapy has evolved rapidly in the past several years with more than 250 clinical trials ongoing around the world. While more indications of cellular therapy with chimeric antigen receptor – engineered T cells (CAR-T) are approved for hematologic malignancies, new concepts and strategi...

Full description

Bibliographic Details
Main Authors: Hongtao Liu, Chongxian Pan, Wenru Song, Delong Liu, Zihai Li, Lei Zheng
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Biomarker Research
Subjects:
Cellular Therapy
CAR-T
TCR-T
Neoantigen
TME
Online Access:https://doi.org/10.1186/s40364-021-00316-6

Similar Items

Similar Items